Medicare Covers Adaptive Biotechnologies’ ClonoSeq Assay GenomeWeb
Following FDA approval last October, Adaptive has now secured Medicare coverage for its NGS-based minimal residual disease assay, ClonoSeq.
Source: Genome Sequencing
Genome Sequencing Information and Domain Names for Sale
Medicare Covers Adaptive Biotechnologies’ ClonoSeq Assay GenomeWeb
Following FDA approval last October, Adaptive has now secured Medicare coverage for its NGS-based minimal residual disease assay, ClonoSeq.
Source: Genome Sequencing